Biopharma News

Feb 13, 2017
By BioPharm International Editors
The company announced results from a Phase II trial with its THC:CBD drug for the treatment of glioblastoma multiforme.
Feb 10, 2017
A total of 166 biotech executives penned an open letter expressing concern over President Donald Trump’s executive order on immigration.
Feb 09, 2017
By BioPharm International Editors
The company is voluntarily recalling product due to particulate matter.
Feb 07, 2017
By BioPharm International Editors
The investment will be used to advance Nemaura’s R&D programs, which include liquid vaccines that have been reformulated for administration through the skin using its micropatch drug delivery technology.
Feb 03, 2017
According to results from the FOURIER trial, Repatha significantly reduced the risk of cardiovascular events and death in patients with atherosclerotic cardiovascular disease.
Feb 01, 2017
By BioPharm International Editors
Novo Nordisk entered a research collaboration with the University of Oxford focused on Type 2 diabetes.
Feb 01, 2017
A change in the tax code could help the company create more jobs in the United States, while fewer FDA regulations could help reduce drug prices, according to Pfizer CEO Ian Read.
Jan 31, 2017
Trump met with pharma manufacturers and makes a statement focused on domestic manufacturing, FDA approvals, and drug pricing.
Jan 31, 2017
By BioPharm International Editors
Lek, a Sandoz company, adds capacity to its plant in Prevalje, Slovenia.
Jan 30, 2017
Alexandre Juillerat, PhD, innovation senior scientist at Cellectis, discusses novel construct UCART123, an investigational agent that is on deck to be the first gene-edited T-cell product in the United States.
native1_300x100
lorem ipsum